Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McKesson Corporation (MCK) vs Wayfair Inc (W) Price & Performance

McKesson CorporationTrade
Wayfair IncTrade

Price performance (Past 24H)

Key statistics

McKesson Corporation vs Wayfair Inc — how do they compare? McKesson Corporation trades at $825.15 (market cap $97.35B), while Wayfair Inc trades at $85.29 (market cap $11.58B). The key difference: McKesson Corporation is far larger — about 8.4× Wayfair Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.

MCKW
Market Cap
$97.35B$11.58B
Sector
HealthConsumer Cyclical
52-Week High
$995.69$119.05
52-Week Low
$659.01$56.42
Enterprise Value
$101.98B$14.16B
Dividend Yield
0.39%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McKesson Corporation

McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.

The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.

Wayfair Inc

Wayfair (W) trades at $87.76, down 1.74% on the day, with a neutral technical signal and mixed earnings history. The company reported revenue of $12.46 billion in 2025 but a net loss of $313 million, reflecting a -2.41% net margin. Positive cash flow from operations of $534 million supports ongoing investments in logistics and new physical stores, as highlighted in recent Bloomberg coverage. Analyst consensus is a Moderate Buy with a $93.58 price target, suggesting modest upside from current levels.

The outlook balances growth initiatives like store expansion and AI integration against persistent profitability challenges. Key risks include high debt-to-asset ratio of 95.11% and competitive e-commerce pressures. Near-term catalyst is the Q2 2026 earnings report on August 4, 2026, where beating the $0.93 EPS expectation could drive momentum. Investors should weigh analyst optimism against fundamental headwinds in the housing market.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK

About Wayfair Inc

Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.

Read more on W